Vlad Bogin, MBA

Chief Executive Officer, Nobilis Therapeutics, Inc.

Portland, Oregon, United States

Professional Overview

Vlad Bogin is an experienced biopharmaceutical executive with a proven track record of leading innovative life sciences companies. As the Chief Executive Officer of Nobilis Therapeutics, Inc., he oversees the strategic direction and operations of the company, leveraging his expertise in drug development, clinical trials, and commercialization.

Experience Summary

Current Role

As the CEO of Nobilis Therapeutics, Inc. since 2016, Vlad Bogin is responsible for driving the company's mission to develop novel therapies for unmet medical needs. Under his leadership, Nobilis Therapeutics has advanced its pipeline of investigational drugs, focusing on areas such as neurological disorders and rare diseases. Bogin's strategic vision and operational expertise have been instrumental in securing funding, forging strategic partnerships, and positioning the company for long-term growth and success.

Career Progression

Prior to joining Nobilis Therapeutics, Bogin served as the Chairman of the Board of Directors and President of Medistem Inc., where he played a pivotal role in the company's acquisition by Intrexon Corporation. He also held a Director position at Boehringer Ingelheim, a leading global pharmaceutical company, where he gained valuable experience in the industry.

Bogin's entrepreneurial spirit led him to found Cromos Pharma in 2006, a contract research organization that provides clinical trial services to biopharmaceutical companies. Under his leadership, Cromos Pharma has grown to become a respected provider of clinical research solutions, contributing to the advancement of numerous drug development programs.

Academic Background

Vlad Bogin holds an MBA from the Wharton School of the University of Pennsylvania, where he specialized in strategic management and entrepreneurship. His academic achievements and formal training have equipped him with the essential business acumen and leadership skills to guide biopharmaceutical companies effectively.

Areas of Expertise

Bogin's areas of expertise include drug development, clinical trial management, strategic planning, and biopharmaceutical industry leadership. He has a deep understanding of the regulatory landscape and a proven ability to navigate the complexities of the life sciences sector. His entrepreneurial mindset and collaborative approach have enabled him to forge successful partnerships and drive the advancement of innovative therapies.

Professional Impact

Throughout his career, Bogin has made significant contributions to the biopharmaceutical industry. His leadership at Nobilis Therapeutics has been instrumental in the company's progress, and his expertise has been recognized by his peers and industry stakeholders. Bogin's commitment to delivering transformative therapies and his passion for addressing unmet medical needs have positioned him as a respected and influential figure in the life sciences community.

Conclusion

Vlad Bogin's extensive experience, strategic vision, and proven track record of success make him a valuable asset to the biopharmaceutical industry. As the CEO of Nobilis Therapeutics, he continues to drive the company's mission to develop innovative therapies that improve the lives of patients worldwide.